ºÐ °ú |
½Ã °£ |
±³ À° ÁÖ Á¦ |
¼Ò ¼Ó |
°»ç¸í |
¼Òȱâ |
¼ÒȱâÁúȯÀÇ ÃֽŠÁö°ß |
09:00¢¦09:40 |
Helicobacter pyloriÀÇ À¯Àü
¿ªÇÐ |
¿¬¼¼ÀÇ´ë |
ÀÌ¿ëÂù |
09:45¢¦10:25 |
¼ÒÀåÁúȯ¿¡¼ Áø´Ü ¹× Ä¡·áÀÇ ÃֽŠÁö°ß |
°í·ÁÀÇ´ë |
ÃÖÀçÇö |
10:30¢¦11:10 |
´ãµµ»óÇǼ¼Æ÷ÀÇ biology |
ÇѾçÀÇ´ë |
ÃÖÈ£¼ø |
11:15¢¦11:55 |
°£¾ÏÀÇ Á¶±â¹ß°ß°ú Ä¡·á¿¡ ´ëÇÑ Á¢±Ù |
ÀüºÏÀÇ´ë |
±è´ë°ï |
¼øȯ±â |
Eschemic Heart
Disease : Update |
09:00¢¦09:35 |
Treatment of acute coronary
syndrome (Unstable angina and non-ST elevation myocardial
infarction) |
Àü³²ÀÇ´ë |
Á¤¸íÈ£ |
09:35¢¦10:10 |
Treatment of acute myocardial
infarction |
¿¬¼¼ÀÇ´ë |
Àå¾ç¼ö |
10:10¢¦10:45 |
Risk modification of coronary
artery disease |
ºÎ»êÀÇ´ë |
È«ÅÃÁ¾ |
10:45¢¦11:20 |
Current update 1 : Basics
and clinical applications of drug-eluting stent |
¿ï»êÀÇ´ë |
¹Ú¼º¿í |
11:20¢¦11:55 |
Current update 2 : Basic
concepts of angiomyogenesis |
ÃæºÏÀÇ´ë |
Á¶¸íÂù |
È£Èí±â |
ÁßȯÀÚ °ü¸®
<ÁÂÀå : ¹Ú¼ø±Ô¡¤À̾ç±Ù> |
09:00¢¦09:30 |
Á¶Àýȯ±â(control mode ventilation)
Àΰø È£Èí±âÀÇ ¿î¿µ |
ÇѾçÀÇ´ë |
¼ÕÀå¿ø |
09:30¢¦10:00 |
±Þ¼ºÈ£Èí°ï¶õÁõÈıºÀÇ ÀΰøÈ£Èí±â Ä¡·á |
¿¬¼¼ÀÇ´ë |
¾Èö¹Î |
10:00¢¦10:30 |
±âµµÆó¼âÁúȯÀÇ ÀΰøÈ£Èí±â Ä¡·á |
¿ï»êÀÇ´ë |
°íÀ±¼® |
10:30¢¦11:00 |
Ư¼ö »óȲ(±âÈä, ½ÉºÎÀü µî)¿¡¼ÀÇ ÀΰøÈ£Èí±â
Ä¡·áÀÇ ½ÇÁ¦ |
¼¿ïÀÇ´ë |
À¯Ã¶±Ô |
11:00¢¦11:30 |
ÀΰøÈ£Èí±âÀÇ ÀÌÅ»ÀÇ ½ÇÁ¦ |
°í·ÁÀÇ´ë |
°°æÈ£ |
11:30¢¦12:00 |
ÀΰøÈ£Èí±âÄ¡·á½Ã ÇÕº´Áõ |
ÀüºÏÀÇ´ë |
ÀÌÈï¹ü |
½Å Àå |
Critical Care
Nephrology |
09:00¢¦09:40 |
Overview of CRRT |
Àü³²ÀÇ´ë |
±è³²È£ |
09:45¢¦10:25 |
CRRT in the critically
ill patients |
ÀÌÈÀÇ´ë |
±è½ÂÁ¤ |
10:30¢¦11:10 |
Poisoning and hemoperfusion |
¼øõÇâÀÇ´ë |
ÀÌÀº¿µ |
11:15¢¦11:55 |
Acute renal failure in
Liver Disease |
µ¿¾ÆÀÇ´ë |
±è¼ºÀº |